Susan Hasty, Publisher
Table of Contents . . . October 21st, 1996Non-Subscriber - Summaries Only
Antisense Technology - Patent Received on Antisense Inhibitor of C-raf Kinase
Carcinogenesis - Newly Discovered Gene Halts Cell Division and May Have Cancer Link
Genetic Testing - Organization Calls for Strong Protections for Genetic Information Use
HIV Gene Therapy - Strategy Developed To Stop HIV By Getting It To Work Against Itself
HIV Gene Therapy - wt-HIV-1 Replication Inhibited by a Conditionally Replicating HIV-1 Vector
Industry News (Funding) - Grants Received To Scale-Up Manufacturing of Products
Industry News (Genomics) - 40,000 Human Genes Discovered Using SBH Technology Reported
Industry News (Genomics) - Advances in Human Genome Analysis Genespectrometry Announced
Industry News (Genomics) - Technology Introduced for Accelerating Genomic Research
Industry News (Licensing) - FAS Gene Licensed as Component of System
Industry News (Licensing) - Human iNOS Gene Licensed for Gene Transfer Pharmaceutical Applications
Industry News (Licensing) - Oncogene Ras Processing Inhibitors Licensed
Industry News (Patents and Technologies) - Allowance Notice Received for Licensed Cancer Technology
Pathogenesis (HIV) - ProSys Used in Programs To Discover Inhibitors of HIV Fusion
Plasmid DNA Vectors - Long-Term Expression of Erythropoietin Possible with Plasmid DNA Vector
Vectors (Transduction) - Amphotropic Retrovirus Transduction Efficiency Dependent on Receptor mRNA
Gene Transfer (Drug Resistance) - "Transfer of Antibiotic Resistance Genes from Bacteria to Mammalian Cells."
Therapy (HBV) - "New Approaches to Hepatitis B Virus Therapy."
Vaccine Development (CMV) - "A New Generation of Live, Attenuated Cytomegalovirus (CMV) Vaccine Strains."
Vaccine Development (EBV) - "Recombinant EBV gp350 as a Subunit Vaccine Candidate to Prevent EBV-Related Disease."
Cancer Gene Therapy - "Active Site-Directed Double Mutants of Dihydrofolate Reductase."
Cancer Gene Therapy - "Constitutive Retinoid Receptors Expressed from Adenovirus Vectors That Specifically Activate Chromosomal Target Genes Required for Differentiation of Promyelocytic Leukemia and Teratocarcinoma Cells."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.